Pag-aaral pangklinika para sa Myositis sa Maryland
7 pag-aaral para sa Myositis ang naghahanap ng mga kalahok sa mga site sa Maryland.
Mga Lungsod sa Maryland
Opisyal na teksto ng pag-aaral (English)
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Johns Hopkins Hospital: Division of Rheumatology, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07103746A Study of AZD0120 in Autoimmune Diseases
- Research Site, Baltimore
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07295847A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Johns Hopkins Hospital, Baltimore
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07085104Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
- The Johns Hopkins Hospital, Baltimore
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07823101Environmental Risk Factors for the Anti-synthetase Syndrome
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT01276470Adult and Juvenile Myositis
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00017914Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.